[1] Global strategy for the diagnosis, management, and prevention of COPD (2025 REPORT). https://goldcopd.org.
[2] Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012; 380, 2095−128. doi:  10.1016/S0140-6736(12)61728-0
[3] Burney P, Kato B, Janson C, et al. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty: a BOLD analysis—authors' reply. Thorax, 2014; 69, 869−70. doi:  10.1136/thoraxjnl-2014-205474
[4] Januszek R, Siudak Z, Dziewierz A, et al. Chronic obstructive pulmonary disease affects the angiographic presentation and outcomes of patients with coronary artery disease treated with percutaneous coronary interventions. Pol Arch Intern Med, 2018; 128, 24−34. doi:  10.20452/pamw.4145
[5] Franssen FME, Soriano JB, Roche N, et al. Lung function abnormalities in smokers with ischemic heart disease. Am J Respir Crit Care Med, 2016; 194, 568−76. doi:  10.1164/rccm.201512-2480OC
[6] Finks SW, Rumbak MJ, Self TH. Treating hypertension in chronic obstructive pulmonary disease. N Engl J Med, 2020; 382, 353−63. doi:  10.1056/NEJMra1805377
[7] Cazzola M, Rogliani P, Calzetta L, et al. Targeting mechanisms linking COPD to type 2 diabetes mellitus. Trends Pharmacol Sci, 2017; 38, 940−51. doi:  10.1016/j.tips.2017.07.003
[8] Mouronte-Roibás C, Leiro-Fernández V, Fernández-Villar A, et al. COPD, emphysema and the onset of lung cancer. A systematic review. Cancer Lett, 2016; 382, 240−4. doi:  10.1016/j.canlet.2016.09.002
[9] Sampilvanjil A, Karasawa T, Yamada N, et al. Cigarette smoke extract induces ferroptosis in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol, 2020; 318, H508−18. doi:  10.1152/ajpheart.00559.2019
[10] Heijink IH, de Bruin HG, Dennebos R, et al. Cigarette smoke-induced epithelial expression of WNT-5B: implications for COPD. Eur Respir J, 2016; 48, 504−15. doi:  10.1183/13993003.01541-2015
[11] Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 2012; 149, 1060−72. doi:  10.1016/j.cell.2012.03.042
[12] Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol, 2016; 26, 165−76. doi:  10.1016/j.tcb.2015.10.014
[13] Dixon SJ, Patel DN, Welsch M, et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife, 2014; 3, e02523. doi:  10.7554/eLife.02523
[14] Yang WS, Kim KJ, Gaschler MM, et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci USA, 2016; 113, E4966−75. doi:  10.1073/pnas.1603244113
[15] Mi YJ, Gao XC, Xu H, et al. The emerging roles of ferroptosis in Huntington's disease. Neuromolecular Med, 2019; 21, 110−9. doi:  10.1007/s12017-018-8518-6
[16] Wang H, An P, Xie EJ, et al. Characterization of ferroptosis in murine models of hemochromatosis. Hepatology, 2017; 66, 449−65. doi:  10.1002/hep.29117
[17] Shen ZY, Song JB, Yung BC, et al. Emerging strategies of cancer therapy based on ferroptosis. Adv Mater, 2018; 30, 1704007. doi:  10.1002/adma.201704007
[18] Li X, Duan LJ, Yuan SJ, et al. Ferroptosis inhibitor alleviates radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1. J Inflamm, 2019; 16, 11. doi:  10.1186/s12950-019-0216-0
[19] Li YC, Cao YM, Xiao J, et al. Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury. Cell Death Differ, 2020; 27, 2635−50. doi:  10.1038/s41418-020-0528-x
[20] Yoshida M, Minagawa S, Araya J, et al. Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis. Nat Commun, 2019; 10, 3145. doi:  10.1038/s41467-019-10991-7
[21] Sato H, Tamba M, Ishii T, et al. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem, 1999; 274, 11455−8. doi:  10.1074/jbc.274.17.11455
[22] La Bella V, Valentino F, Piccoli T, et al. Expression and developmental regulation of the cystine/glutamate exchanger (Xc-) in the rat. Neurochem Res, 2007; 32, 1081−90. doi:  10.1007/s11064-006-9277-6
[23] Spector AA, Fang X, Snyder GD, et al. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res, 2004; 43, 55−90. doi:  10.1016/s0163-7827(03)00049-3
[24] Wagner KM, McReynolds CB, Schmidt WK, et al. Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases. Pharmacol Ther, 2017; 180, 62−76. doi:  10.1016/j.pharmthera.2017.06.006
[25] Smith KR, Pinkerton KE, Watanabe T, et al. Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc Natl Acad Sci USA, 2005; 102, 2186−91. doi:  10.1073/pnas.0409591102
[26] Hu SQ, Luo JL, Fu ML, et al. Soluble epoxide hydrolase deletion attenuated nicotine-induced arterial stiffness via limiting the loss of SIRT1. Am J Physiol Heart Circ Physiol, 2021; 321, H353−68. doi:  10.1152/ajpheart.00979.2020
[27] Luo XQ, Duan JX, Yang HH, et al. Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages. J Cell Physiol, 2020; 235, 9910−21. doi:  10.1002/jcp.29806
[28] Wang L, Yang J, Guo L, et al. Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol, 2012; 46, 614−22. doi:  10.1165/rcmb.2011-0359OC
[29] Li YX, Yu GG, Yuan SP, et al. Cigarette smoke-induced pulmonary inflammation and autophagy are attenuated in Ephx2-deficient mice. Inflammation, 2017; 40, 497−510. doi:  10.1007/s10753-016-0495-z
[30] Sinal CJ, Miyata M, Tohkin M, et al. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem, 2000; 275, 40504−10. doi:  10.1074/jbc.M008106200
[31] Crowley G, Kwon S, Caraher EJ, et al. Quantitative lung morphology: Semi-automated measurement of mean linear intercept. BMC Pulm Med, 2019; 19, 206. doi:  10.1186/s12890-019-0915-6
[32] Meng LY, Tao WF, Li J, et al. Effects of bisphenol A and its substitute, bisphenol F, on the gut microbiota in mice. Biomed Environ Sci, 2024; 37, 19−30.
[33] Alves CE, Santos TG, Vitoretti LB, et al. Effect of photobiomodulation therapy in an experimental model of chronic obstructive pulmonary disease: a dosimetric study. Allergies, 2025; 5, 33. doi:  10.3390/allergies5040033
[34] Janssen R, Piscaer I, Franssen FME, et al. Emphysema: looking beyond alpha-1 antitrypsin deficiency. Expert Rev Respir Med, 2019; 13, 381−97. doi:  10.1080/17476348.2019.1580575
[35] Harris TR, Hammock BD. Soluble epoxide hydrolase: gene structure, expression and deletion. Gene, 2013; 526, 61−74. doi:  10.1016/j.gene.2013.05.008
[36] Li YX, Yu GG, Yuan SP, et al. 14, 15-Epoxyeicosatrienoic acid suppresses cigarette smoke condensate-induced inflammation in lung epithelial cells by inhibiting autophagy. Am J Physiol Lung Cell Mol Physiol, 2016; 311, L970−80. doi:  10.1152/ajplung.00161.2016
[37] Yagoda N, von Rechenberg M, Zaganjor E, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature, 2007; 447, 865−9. doi:  10.1038/nature05859
[38] Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol, 2017; 13, 91−8. doi:  10.1038/nchembio.2239
[39] Ye LF, Chaudhary KR, Zandkarimi F, et al. Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers. ACS Chem Biol, 2020; 15, 469−84. doi:  10.1021/acschembio.9b00939
[40] Ghio AJ, Hilborn ED, Stonehuerner JG, et al. Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect. Am J Respir Crit Care Med, 2008; 178, 1130−8. doi:  10.1164/rccm.200802-334OC
[41] Park EJ, Park YJ, Lee SJ, et al. Whole cigarette smoke condensates induce ferroptosis in human bronchial epithelial cells. Toxicol Lett, 2019; 303, 55−66. doi:  10.1016/j.toxlet.2018.12.007
[42] Jiang XJ, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol, 2021; 22, 266−82. doi:  10.1038/s41580-020-00324-8
[43] Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med, 2019; 133, 144−52. doi:  10.1016/j.freeradbiomed.2018.09.014
[44] Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell, 2014; 156, 317−31. doi:  10.1016/j.cell.2013.12.010
[45] Seiler A, Schneider M, Förster H, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab, 2008; 8, 237−48. doi:  10.1016/j.cmet.2008.07.005
[46] Lo M, Ling V, Wang YZ, et al. The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance. Br J Cancer, 2008; 99, 464−72. doi:  10.1038/sj.bjc.6604485
[47] Xiang P, Chen QQ, Chen L, et al. Metabolite Neu5Ac triggers SLC3A2 degradation promoting vascular endothelial ferroptosis and aggravates atherosclerosis progression in ApoE-/- mice. Theranostics, 2023; 13, 4993−5016. doi:  10.7150/thno.87968
[48] Zheng YQ, Zhou SL, Tao YR, et al. Elevated SLC3A2 expression promotes the progression of gliomas and enhances ferroptosis resistance through the AKT/NRF2/GPX4 axis. Cancer Res Treat, 2025; 10. (查阅网上资料, 未找到本条文献卷号和页码, 请确认)